RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Financials
  4. Free cash flow

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$345.05M
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 2024-58+1.68%
Dec 31, 2023-57+2.51%
Dec 31, 2022-56+25.64%
Dec 31, 2021-44+14.48%
Dec 31, 2020-39+20.15%
Dec 31, 2019-32-6.84%
Dec 31, 2018-35-5.25%
Dec 31, 2017-37-39.76%
Dec 31, 2016-61-29.02%
Dec 31, 2015-85+98.87%
Dec 31, 2013-43+53.97%
Dec 31, 2012-28+40.80%
Dec 31, 2011-20

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)